About Xcenda
Xcenda is a company based in Conshohocken (United States) founded in 1994 was acquired by AmerisourceBergen in April 2017. The company has 7 employees. Xcenda has completed 1 acquisition, including Dymaxium. Xcenda offers products and services including Commercialization Solutions, Health Economics Research, Reimbursement Insights, and Global Market Access Consulting. Xcenda operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
- Headquarter Conshohocken, United States
- Employees 7
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website xcenda.com
- Social LinkedIn X Instagram
- Acquired by AmerisourceBergen (Apr 2017)
- Legal Name Xcenda (Uk) Limited
- Annual Revenue$3.5 M (USD)22as on Sep 30, 2023
- Net Profit$915.14 K (USD)14as on Sep 30, 2023
- Investors
- Employee Count7
- Investments & Acquisitions
- Acquired byAmerisourceBergen
(Apr 2017)
Products & Services of Xcenda
Xcenda offers a comprehensive portfolio of products and services, including Commercialization Solutions, Health Economics Research, Reimbursement Insights, and Global Market Access Consulting.
Provides strategies for product launch and market access in pharmaceuticals
Conducts outcomes analysis for healthcare decision-making processes
Offers policy guidance on reimbursement and payer strategies
Assists in navigating international market entry for products
Investors in Xcenda
Xcenda has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include AmerisourceBergen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical distribution and supply chain services are provided globally. | 1985 | amerisourcebergen.com | Chesterbrook, United States |
Investor details for Xcenda
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Xcenda
23 people are tracked at Xcenda (17 in leadership, 6 in team); the tracked headcount is 7.
| Name | Role | Group |
|---|---|---|
Thomas Mittendorf | Managing Director | Leadership |
Gene Reeder | Director, Strategic Market Insights | Leadership |
Kellie Meyer | Vice President, Evidence Generation & Value Communications | Leadership |
Paula Hilton | Associate Director, Strategic Market Intelligence- Quantitative | Leadership |
Erika Wissinger | Senior Director, Evidence Generation & Global Value Communications | Leadership |
Kevin Byerly | Senior Director | Leadership |
Myra Reinhardt | Vice President, Product Innovation | Leadership |
Jayne Hurrell | Director, Value & Access Communications | Leadership |
Willis Chandler | President, Global Pharma Services | Leadership |
Ana Stojanovska | Vice President, Commercialization Strategy & Access Solutions | Leadership |
Jason Lynch | Director Of Product Development | Leadership |
Bryan Horveath | Vice President, Sales Effectiveness & Learning Solutions | Leadership |
Kim Boswell | Senior Director, Value & Access Communications | Leadership |
Megan Bodge Dillaman | Assistant Director, Oncology Strategy & Communications | Leadership |
Kiran Laxman | Senior Director, Evidence Generation & Value Communications | Global Dossiers | Leadership |
Maren Fustgaard | Senior Director | Leadership |
Heather de la Cruz | Associate Director, Sales Operations | Leadership |
Shivam Patel | Value & Access Strategy | Team |
Lauren Hutchinson | Manager, Prospective Research | Team |
Steve Wilson | Manager | Team |
3 more people are available in the full profile.
Complete people profiles for Xcenda
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xcenda
Xcenda has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dymaxium.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Platform for life sciences companies for reimbursement and market access solutions | dymaxium.com | Toronto, Canada | 1996 | May 2019 | •••• |
Complete acquisition details for Xcenda
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Xcenda
3 dated milestones of Xcenda across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Xcenda is founded.
- Exit Acquired by AmerisourceBergen.
- Acquisition Acquires Dymaxium.
Competitors of Xcenda
Xcenda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openhealthgroup.com | 2016 | Marlow, United Kingdom | $5.28M | 297 | Provider of healthcare marketing services | |
| targetrwe.com | 2017 | Durham, United States | – | 116 | Marketing services to the pharmaceutical industry are provided. | |
| securabio.com | 2018 | Henderson, United States | $55M | – | Consulting services for market access and health outcomes are provided. | |
| statinmed.com | 2007 | Ann Arbor, United States | – | – | Healthcare data analytics services provider | |
| abacusmedicine.com | 2004 | Copenhagen, Denmark | $57.64M | 1,052 | Consulting services for market access, health economics and outcomes research | |
| hylant.com | 1935 | Toledo, United States | – | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. | |
| gba-group.com | 1975 | Hamburg, Germany | – | – | GBA Group is recognized as a leading life sciences service provider. | |
| huameihaolian.com | 2021 | China | – | – | Commercial services for biopharma sector are provided by Huameihaolian. |
Detailed competitors of Xcenda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Xcenda
Websites that share an audience with Xcenda (xcenda.com).
Websites whose visitors overlap most with Xcenda. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rinvoqhcp.com | rinvoqhcp.com | 100% | – | #1,291,015 | – |
biosimilarsrr.com | biosimilarsrr.com | 99% | – | – | – |
journavxhcp.com | journavxhcp.com | 67% | – | #800,186 | – |
| skyrizihcp.com | 60% | – | #1,526,193 | View details | |
| imshealth.com | 57% | 11.7K | #1,292,597 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Xcenda
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Xcenda
Complete news archive for Xcenda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Xcenda
10 companies that operate in the same segment as Xcenda (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Xcenda
Xcenda was founded in 1994.
Xcenda is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.
Xcenda has 7 employees.
Annual revenue of Xcenda is $3.5M as on Sep 30, 2023.
Xcenda was founded in 1994 and is based in Conshohocken, United States. Operations focus on the biopharma industry, where commercialisation strategies and health economics and outcomes research (HEOR) services are delivered. These offerings support market access, pricing, and evidence generation for pharmaceutical clients. Leadership includes Thomas Mittendorf as Managing Director, overseeing service provision across the sector.
Xcenda's top competitors include OPEN Health, Abacus Medicine and Target RWE.
Xcenda offers Commercialization Solutions, Health Economics Research, Reimbursement Insights, and Global Market Access Consulting.
Xcenda has made 1 acquisition, including Dymaxium.
Xcenda has 1 investor. Key investors include AmerisourceBergen.
Xcenda operates through Xcenda (Uk) Limited.
Yes. Xcenda was acquired by AmerisourceBergen in April 2017.